Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form of skin cancer. After being acquired by Johnson & Johnson
Tag "Actelion"
Johnson & Johnson is counting on new buy Actelion’s pulmonary arterial hypertension (PAH) meds to provide a top-line boost once its $30 billion transaction closes. But one of them may
Advertisements
